Compositions comprising organic compounds

Details for Australian Patent Application No. 2004292768 (hide)

Owner Novartis AG

Inventors Ogorka, Jorg; Decouz, Armelle; Cassiere, Jean-Pierre; Desset-Brethes, Sabine; Meyer, Andreas

Agent Davies Collison Cave

Pub. Number AU-B-2004292768

PCT Pub. Number WO2005/051346

Priority 60/525,373 26.11.03 US

Filing date 25 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 2 April 2009

International Classifications

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/47 (2006.01) - Quinolines

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051346 Priority application(s): WO2005/051346

2 April 2009 Application Accepted

  Published as AU-B-2004292768

30 July 2009 Standard Patent Sealed

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292773-Diaryl urea derivatives in the treatment of protein kinase dependent diseases

2004292765-Plant extracts for the treatment of increased bone resorption